Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 10.Ident. | Authors (with country if any) | Title |
---|---|---|
000750 | G. O. Skeie [Norvège] ; B. Muller [Norvège] ; K. Haugarvoll [Norvège] ; J. P. Larsen [Norvège] ; O. B. Tysnes [Norvège] | Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease |
001206 | M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease |
001207 | M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease |
001318 | C. Vossius [Norvège] ; M. Gjerstad [Norvège] ; H. Baas [Allemagne] ; J. P. Larsen [Norvège] | Drug costs for patients with Parkinson's disease in two different European countries |
001404 | K. Haugarvoll [Norvège] ; D. Aarsland [Norvège] ; T. Wentzel-Larsen [Norvège] ; J. P. Larsen [Norvège] | The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease |
001695 | K. Herlofson [Norvège] ; J. P. Larsen [Norvège] | The influence of fatigue on health‐related quality of life in patients with Parkinson's disease |
001769 | M. Kurz ; G. Alves ; D. Aarsland [Norvège] ; J. P. Larsen | Familial Parkinson's disease: a community‐based study |
001D66 | D. Aarsland [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège] ; N. G. Lim [Norvège] ; E. Tandberg [Norvège] | Mental symptoms in Parkinson's disease are important contributors to caregiver distress |
002033 | V. V. Myllyl [Finlande] ; M. Jackson [Royaume-Uni] ; J. P. Larsen [Norvège] ; H. Baas [Allemagne] | Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial |
002448 | J. P. Larsen [Norvège] ; E. Dupont [Danemark] ; E. Tandberg [Norvège] | Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence |
This area was generated with Dilib version V0.6.23. |